Patents by Inventor William M. Trolio

William M. Trolio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DUAL ANTI-PLATELET MEDICATION/ASPIRIN RESPONSE AND REACTIVITY TEST USING SYNTHETIC COLLAGEN
    Publication number: 20190004070
    Abstract: The present invention provides tests that measures functional platelet aggregation such as by using Light Transmission Aggregometry Assays (LTAAs) or flow cytometry, using synthetic, self-assembling human type I collagen, methods of predicting and measuring an individual's platelet anti-platelet medication sensitivity and residual platelet activity status when the individual is on a dual anti-platelet therapy of aspirin and anti-platelet medication and kits useful in the assays and methods.
    Type: Application
    Filed: January 18, 2018
    Publication date: January 3, 2019
    Applicant: JNC CORPORATION
    Inventor: William M. TROLIO
  • ANTI-PLATELET RESPONSE AND REACTIVITY TEST USING SYNTHETIC COLLAGEN
    Publication number: 20180306819
    Abstract: The present invention provides platelet aggregation tests using synthetic, self-assembling type I human collagen, methods of measuring an individual's platelet anti-platelet medication sensitivity and residual platelet activity status when the individual is on a an anti-platelet medication and kits useful in the assays and methods.
    Type: Application
    Filed: January 25, 2018
    Publication date: October 25, 2018
    Inventor: William M. TROLIO
  • DUAL ANTI-PLATELET MEDICATION/ASPIRIN RESPONSE AND REACTIVITY TEST USING SYNTHETIC COLLAGEN
    Publication number: 20180172713
    Abstract: The present invention provides tests that measures functional platelet aggregation such as by using Light Transmission Aggregometry Assays (LTAAs) or flow cytometry, using synthetic, self-assembling human type I collagen, methods of predicting and measuring an individual's platelet anti-platelet medication sensitivity and residual platelet activity status when the individual is on a dual anti-platelet therapy of aspirin and anti-platelet medication and kits useful in the assays and methods.
    Type: Application
    Filed: January 18, 2018
    Publication date: June 21, 2018
    Applicant: JNC CORPORATION
    Inventor: William M. TROLIO
  • ASPIRIN RESPONSE AND REACTIVITY TEST AND ASPIRIN COMPLIANCE TEST USING SYNTHETIC COLLAGEN
    Publication number: 20180128811
    Abstract: The present invention provides platelet aggregation assays using synthetic collagen, methods of measuring a donor's platelet aspirin sensitivity status and residual platelet reactivity, and aspiring therapy compliance using synthetic collagen. The invention further provides kits useful in the assays and methods.
    Type: Application
    Filed: July 5, 2013
    Publication date: May 10, 2018
    Inventor: William M. TROLIO
  • DUAL ANTI-PLATELET MEDICATION/ASPIRIN RESPONSE AND REACTIVITY TEST USING SYNTHETIC COLLAGEN
    Publication number: 20150226756
    Abstract: The present invention provides tests that measures functional platelet aggregation such as by using Light Transmission Aggregometry Assays (LTAAs) or flow cytometry, using synthetic, self-assembling human type I collagen, methods of predicting and measuring an individual's platelet anti-platelet medication sensitivity and residual platelet activity status when the individual is on a dual anti-platelet therapy of aspirin and anti-platelet medication and kits useful in the assays and methods.
    Type: Application
    Filed: August 5, 2013
    Publication date: August 13, 2015
    Applicant: JNC CORPORATION
    Inventor: William M. Trolio
  • ANTI-PLATELET RESPONSE AND REACTIVITY TEST USING SYNTHETIC COLLAGEN
    Publication number: 20150198620
    Abstract: The present invention provides platelet aggregation tests using synthetic, self-assembling type I human collagen, methods of measuring an individual's platelet anti-platelet medication sensitivity and residual platelet activity status when the individual is on a an anti-platelet medication and kits useful in the assays and methods.
    Type: Application
    Filed: August 8, 2013
    Publication date: July 16, 2015
    Applicant: JNC CORPORATION
    Inventor: William M. Trolio